StockData
Core Laboratories Inc. logo

Core Laboratories Inc. (CLB) stock

CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/300% above fair value
$8.39−0.06 (-0.71%)

Close on Nov 17, 2026Market cap $384.46MP/E 24.7Yield 0.48%

Core Laboratories operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Core Laboratories's operating income for the twelve months ending Sep 30, 2026 was $38.94M, down 29.0% year over year. For fiscal 2025 it was $56.47M, down 3.6% from the year before. The highest annual figure on record is $58.56M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$56.47M-3.6%
FY2024Dec 31, 2024$58.56M+7.2%
FY2023Dec 31, 2023$54.64M+31.6%
FY2022Dec 31, 2022$41.52M-8.3%
FY2021Dec 31, 2021$45.26M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$12.07M-42.3%
Q2 FY2026Jun 30, 2026$9.15M-40.2%
Q1 FY2026Mar 31, 2026$1.89M-57.3%
Q4 FY2025Dec 31, 2025$15.83M+11.7%
Q3 FY2025Sep 30, 2025$20.93M+5.7%
Q2 FY2025Jun 30, 2025$15.29M-4.5%
Q1 FY2025Mar 31, 2025$4.42M-48.5%
Q4 FY2024Dec 31, 2024$14.17M-2.8%
Q3 FY2024Sep 30, 2024$19.80M+35.0%
Q2 FY2024Jun 30, 2024$16.01M-15.3%
Q1 FY2024Mar 31, 2024$8.57M+32.2%
Q4 FY2023Dec 31, 2023$14.58M-6.6%
Q3 FY2023Sep 30, 2023$14.67M+0.2%
Q2 FY2023Jun 30, 2023$18.91M+62.3%
Q1 FY2023Mar 31, 2023$6.48M–
Q4 FY2022Dec 31, 2022$15.62M–
Q3 FY2022Sep 30, 2022$14.65M–
Q2 FY2022Jun 30, 2022$11.65M–

More Core Laboratories figures

See a number that looks wrong?